miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors
Open Access
- 5 April 2013
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 8 (1) , 55
Abstract
Background: Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant muscle disorder, which is linked to the contraction of the D4Z4 array at chromosome 4q35. Recent studies suggest that this shortening of the D4Z4 array leads to aberrant expression of double homeobox protein 4 (DUX4) and causes FSHD. In addition, misregulation of microRNAs (miRNAs) has been reported in muscular dystrophies including FSHD. In this study, we identified a miRNA that is differentially expressed in FSHD myoblasts and investigated its function. Methods: To identify misregulated miRNAs and their potential targets in FSHD myoblasts, we performed expression profiling of both miRNA and mRNA using TaqMan Human MicroRNA Arrays and Affymetrix Human Genome U133A plus 2.0 microarrays, respectively. In addition, we over-expressed miR-411 in C2C12 cells to determine the effect of miR-411 on myogenic markers. Results: Using miRNA and mRNA expression profiling, we identified 8 miRNAs and 1,502 transcripts that were differentially expressed in FSHD myoblasts during cell proliferation. One of the 8 differentially expressed miRNAs, miR-411, was validated by quantitative RT-PCR in both primary (2.1 fold, p2C12 cells were transfected with miR-411 to determine whether miR-411 affects YAF2 expression in myoblasts. The results showed that over-expression of miR-411 reduced YAF2 mRNA expression. In addition, expression of myogenic markers including Myod, myogenin, and myosin heavy chain 1 (Myh1) were suppressed by miR-411. Conclusions: The study demonstrated that miR-411 was differentially expressed in FSHD myoblasts and may play a role in regulating myogenesis.Keywords
This publication has 95 references indexed in Scilit:
- Generation of Isogenic D4Z4 Contracted and Noncontracted Immortal Muscle Cell Clones from a Mosaic PatientThe American Journal of Pathology, 2012
- DUX4 Activates Germline Genes, Retroelements, and Immune Mediators: Implications for Facioscapulohumeral DystrophyDevelopmental Cell, 2012
- A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell functionEuropean Journal of Human Genetics, 2011
- The isolated muscle fibre as a model of disuse atrophy: Characterization using PhAct, a method to quantify f-actinExperimental Cell Research, 2011
- MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS PathwayCell Metabolism, 2010
- Genome-wide MyoD Binding in Skeletal Muscle Cells: A Potential for Broad Cellular ReprogrammingDevelopmental Cell, 2010
- Mef2‐mediated transcription of the miR379–410 cluster regulates activity‐dependent dendritogenesis by fine‐tuning Pumilio2 protein levelsThe EMBO Journal, 2009
- An isogenetic myoblast expression screen identifies DUX4‐mediated FSHD‐associated molecular pathologiesThe EMBO Journal, 2008
- Facioscapulohumeral Muscular DystrophyNeurotherapeutics, 2008
- The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiationNature Cell Biology, 2006